Crispr Therapeutics shares tumble after significant earnings miss
Norfolk Southern Corporation (NYSE:NSC), a major railroad operator with a market capitalization of $50.5 billion and current trading price of $224.07, announced the outcomes of its 2025 Annual Meeting of Shareholders held on May 8, 2025. The results of the meeting were filed with the U.S. Securities and Exchange Commission (SEC) on May 9, 2025. According to InvestingPro analysis, the company currently appears undervalued based on its Fair Value calculations, with analysts maintaining a moderate buy consensus.
During the meeting, shareholders elected thirteen directors to serve one-year terms on the company’s board. The directors were elected by a majority of votes, with the number of votes withheld and broker non-votes also reported for each director.
Additionally, the appointment of KPMG LLP as Norfolk Southern’s independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified by shareholders. The proposal received a significant number of affirmative votes against a smaller number of votes against and abstentions.
Shareholders also approved, on an advisory basis, the executive compensation as disclosed in the proxy statement for the 2025 Annual Meeting. This "Say on Pay" resolution passed with a majority of votes in favor, with some votes against and abstentions, alongside a number of broker non-votes.
The filing confirmed that all matters submitted to a vote at the annual meeting were determined by the shareholders on the date reported. The detailed voting results for each proposal, including the number of votes for, against, abstentions, and broker non-votes, were included in the SEC filing. The information provided is based on the official 8-K document filed by Norfolk Southern Corporation.
In other recent news, Norfolk Southern Corporation’s Q1 2025 earnings report highlighted mixed financial results, with earnings per share (EPS) of $2.69, falling short of the forecasted $2.81. Despite this, the company maintained stable revenue at approximately $2.99 billion year-over-year. Analysts from UBS, Benchmark, and Jefferies reaffirmed their Buy ratings, with price targets set at $275, $265, and $260, respectively, reflecting confidence in Norfolk Southern’s operational improvements and cost-saving initiatives. However, BMO Capital Markets adjusted its price target to $255, citing concerns over weakening demand and a challenging macroeconomic outlook. Norfolk Southern’s management remains committed to achieving $150 million in cost savings by 2025 and anticipates a 3% revenue growth for the year. The company also reported significant operational efficiencies, including a 43% reduction in train accident frequency and improved fuel efficiency. Despite the challenges, Norfolk Southern’s strategic responses and resilience have positioned it to navigate economic uncertainties effectively.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.